Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Бактериальный (септический) артрит и инфекция протезированного сустава
Бактериальный (септический) артрит и инфекция протезированного сустава
Белов Б.С., Макаров С.А., Бялик Е.И. Бактериальный (септический) артрит и инфекция протезированного сустава. Consilium Medicum. 2016; 18 (12): 110–116. DOI: 10.26442/2075-1753_2016.12.110-116
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В настоящее время проблемы бактериального артрита (БА) и инфекций протезированного сустава представляются весьма актуальными. БА и инфекции протезированного сустава являются причиной 0,2–0,7% всех госпитализаций в год. Частота летальных исходов при БА существенно не изменилась за последние 25 лет и составляет 5–15%. В статье представлены современные данные об этиологии, патогенезе, клинической картине, диагностике и лечении указанных нозологических форм.
Ключевые слова: бактериальный артрит, инфекция протезированного сустава, диссеминированная гонококковая инфекция, антибактериальная терапия, профилактика.
Ключевые слова: бактериальный артрит, инфекция протезированного сустава, диссеминированная гонококковая инфекция, антибактериальная терапия, профилактика.
________________________________________________
Currently, the problem of bacterial arthritis (BA) and prosthetic joint infections seems to be very relevant. BA and prosthetic joint infections are the cause of 0.2–0.7% of all hospital admissions per year. The frequency of deaths in asthma has not changed significantly over the past 25 years and is 5–15%. The article presents modern data on etiology, pathogenesis, clinical presentation, diagnosis and treatment of these clinical entities.
Key words: bacterial arthritis, prosthetic joint infections, disseminated gonococcal infection, antibiotic therapy, prevention.
Полный текст
Список литературы
1. Balsa A, Martin-Mola E. Infectious arthritis: bacterial arthritis. In: Hochberg ML, Silman AJ,Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 6th ed. Philadelphia: Mosby, 2015; p. 885–93.
2. Kennedy N, Chambers ST, Nolan I et al. Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population. J Rheumatol 2015; 42 (12): 2392–7.
3. Ohl CA, Forster D. Infectious arthritis of native joints. In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier-Saunders, 2015; p. 1302–17.
4. Храмов А.Э., Макаров М.А., Бялик Е.И. и др. Проблемы диагностики, профилактики и лечения перипротезной инфекции у больных ревматическими заболеваниями. Научно-практическая ревматология. 2015; 5: 558–63. / Khramov A.E., Makarov M.A., Bialik E.I. i dr. Problemy diagnostiki, profilaktiki i lecheniia periproteznoi infektsii u bol'nykh revmaticheskimi zabolevaniiami. Nauchno-prakticheskaia revmatologiia. 2015; 5: 558–63. [in Russian]
5. Пичхадзе И.М., Жадин А.В., Кузьменков В.А. и др. Лечение больных с гнойно-воспалительными осложнениями после эндопротезирования тазобедренного сустава. Вестн. травматологии и ортопедии им. Н.Н.Приорова. 2009; 3: 45–50. / Pichkhadze I.M., Zhadin A.V., Kuz'menkov V.A. i dr. Lechenie bol'nykh s gnoino-vospalitel'nymi oslozhneniiami posle endoprotezirovaniia tazobedrennogo sustava. Vestn. travmatologii i ortopedii im. N.N.Priorova. 2009; 3: 45–50. [in Russian]
6. Colavite PM, Sartori A. Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis 2014; 20: 19.
7. Lahmann JD, Lahmann SJ. Etiology of septic arthritis in children: an update for the 1990s. Pediatr Emerg Care 1999; 15: 40–2.
8. Wang DA, Tambyah PA. Septic arthritis in immunocompetent and immunosuppressed hosts. Best Pract Res Clin Rheumatol 2015; 29 (2): 275–89.
9. Maki DG. Risk for septic arthritis was increased in adults with incident diagnosis of gout. Ann Intern Med 2015; 163 (12): JC12.
10. Lim SY, Lu N, Choi HK. Septic arthritis in gout patients: a population-based cohort study. Rheumatology (Oxford) 2015; 54 (11): 2095–9.
11. Galloway JB, Hyrich KL, Mercer LK et al. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70 (10): 1810–4.
12. Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol 2003; 17 (2): 201–8.
13. Cucurull E, Espinosa LR. Gonococcal arthritis. Rheum Dis Clin North America 1998; 24: 305–22.
14. Kaandorp CJ, van Schaardenburg D, Krijnen P et al. Risk factors for septic arthritis in patient with joint disease. A prospective study. Arthritis Rheum 1995; 38: 1819–25.
15. Rodríguez-Baño J, del Toro MD, Lupión C et al. Arthroplasty-related infection: incidence, risk factors, clinical features, and outcome. Enferm Infecc Microbiol Clin 2008; 26 (10): 614–20.
16. Müller M, Morawietz L, Hasart O et al. Diagnosis of periprosthetic infection following total hip arthroplasty – evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008; 3: 31.
17. Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA 2007; 297 (13): 1478–88.
18. Paosong S, Narongroeknawin P, Pakchotanon R et al. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Int J Rheum Dis 2015; 18 (3): 352–9.
19. Shaikh MM, Hermans LE, van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology 2015; 54 (2): 231–40.
20. Schäfer P, Fink B, Sandow D et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 2008; 47 (11): 1403–9.
21. Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357 (7): 654–63.
22. Workgroup Convened by the Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplasty 2011; 26 (8): 1136–8.
23. Osmon DR, Berbari EF, Berendt AR et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56 (1): e1–e25.
24. Rao N. Septic arthritis. Curr Treat Opt Infect Dis 2002; 4: 279–87.
25. Trampuz A, Steckelberg JM. Septic arthritis. Curr Treat Opt Infect Dis 2003; 5: 337–44.
26. Urologic surgery antimicrobial prophylaxis. Pocket Guide, May 15, 2013 version. URL: http://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis-PocketTable.p...
2. Kennedy N, Chambers ST, Nolan I et al. Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population. J Rheumatol 2015; 42 (12): 2392–7.
3. Ohl CA, Forster D. Infectious arthritis of native joints. In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier-Saunders, 2015; p. 1302–17.
4. Khramov A.E., Makarov M.A., Bialik E.I. i dr. Problemy diagnostiki, profilaktiki i lecheniia periproteznoi infektsii u bol'nykh revmaticheskimi zabolevaniiami. Nauchno-prakticheskaia revmatologiia. 2015; 5: 558–63. [in Russian]
5. Pichkhadze I.M., Zhadin A.V., Kuz'menkov V.A. i dr. Lechenie bol'nykh s gnoino-vospalitel'nymi oslozhneniiami posle endoprotezirovaniia tazobedrennogo sustava. Vestn. travmatologii i ortopedii im. N.N.Priorova. 2009; 3: 45–50. [in Russian]
6. Colavite PM, Sartori A. Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis 2014; 20: 19.
7. Lahmann JD, Lahmann SJ. Etiology of septic arthritis in children: an update for the 1990s. Pediatr Emerg Care 1999; 15: 40–2.
8. Wang DA, Tambyah PA. Septic arthritis in immunocompetent and immunosuppressed hosts. Best Pract Res Clin Rheumatol 2015; 29 (2): 275–89.
9. Maki DG. Risk for septic arthritis was increased in adults with incident diagnosis of gout. Ann Intern Med 2015; 163 (12): JC12.
10. Lim SY, Lu N, Choi HK. Septic arthritis in gout patients: a population-based cohort study. Rheumatology (Oxford) 2015; 54 (11): 2095–9.
11. Galloway JB, Hyrich KL, Mercer LK et al. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70 (10): 1810–4.
12. Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol 2003; 17 (2): 201–8.
13. Cucurull E, Espinosa LR. Gonococcal arthritis. Rheum Dis Clin North America 1998; 24: 305–22.
14. Kaandorp CJ, van Schaardenburg D, Krijnen P et al. Risk factors for septic arthritis in patient with joint disease. A prospective study. Arthritis Rheum 1995; 38: 1819–25.
15. Rodríguez-Baño J, del Toro MD, Lupión C et al. Arthroplasty-related infection: incidence, risk factors, clinical features, and outcome. Enferm Infecc Microbiol Clin 2008; 26 (10): 614–20.
16. Müller M, Morawietz L, Hasart O et al. Diagnosis of periprosthetic infection following total hip arthroplasty – evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008; 3: 31.
17. Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA 2007; 297 (13): 1478–88.
18. Paosong S, Narongroeknawin P, Pakchotanon R et al. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Int J Rheum Dis 2015; 18 (3): 352–9.
19. Shaikh MM, Hermans LE, van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology 2015; 54 (2): 231–40.
20. Schäfer P, Fink B, Sandow D et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 2008; 47 (11): 1403–9.
21. Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357 (7): 654–63.
22. Workgroup Convened by the Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplasty 2011; 26 (8): 1136–8.
23. Osmon DR, Berbari EF, Berendt AR et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56 (1): e1–e25.
24. Rao N. Septic arthritis. Curr Treat Opt Infect Dis 2002; 4: 279–87.
25. Trampuz A, Steckelberg JM. Septic arthritis. Curr Treat Opt Infect Dis 2003; 5: 337–44.
26. Urologic surgery antimicrobial prophylaxis. Pocket Guide, May 15, 2013 version. URL: http://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis-PocketTable.p...
2. Kennedy N, Chambers ST, Nolan I et al. Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population. J Rheumatol 2015; 42 (12): 2392–7.
3. Ohl CA, Forster D. Infectious arthritis of native joints. In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier-Saunders, 2015; p. 1302–17.
4. Храмов А.Э., Макаров М.А., Бялик Е.И. и др. Проблемы диагностики, профилактики и лечения перипротезной инфекции у больных ревматическими заболеваниями. Научно-практическая ревматология. 2015; 5: 558–63. / Khramov A.E., Makarov M.A., Bialik E.I. i dr. Problemy diagnostiki, profilaktiki i lecheniia periproteznoi infektsii u bol'nykh revmaticheskimi zabolevaniiami. Nauchno-prakticheskaia revmatologiia. 2015; 5: 558–63. [in Russian]
5. Пичхадзе И.М., Жадин А.В., Кузьменков В.А. и др. Лечение больных с гнойно-воспалительными осложнениями после эндопротезирования тазобедренного сустава. Вестн. травматологии и ортопедии им. Н.Н.Приорова. 2009; 3: 45–50. / Pichkhadze I.M., Zhadin A.V., Kuz'menkov V.A. i dr. Lechenie bol'nykh s gnoino-vospalitel'nymi oslozhneniiami posle endoprotezirovaniia tazobedrennogo sustava. Vestn. travmatologii i ortopedii im. N.N.Priorova. 2009; 3: 45–50. [in Russian]
6. Colavite PM, Sartori A. Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis 2014; 20: 19.
7. Lahmann JD, Lahmann SJ. Etiology of septic arthritis in children: an update for the 1990s. Pediatr Emerg Care 1999; 15: 40–2.
8. Wang DA, Tambyah PA. Septic arthritis in immunocompetent and immunosuppressed hosts. Best Pract Res Clin Rheumatol 2015; 29 (2): 275–89.
9. Maki DG. Risk for septic arthritis was increased in adults with incident diagnosis of gout. Ann Intern Med 2015; 163 (12): JC12.
10. Lim SY, Lu N, Choi HK. Septic arthritis in gout patients: a population-based cohort study. Rheumatology (Oxford) 2015; 54 (11): 2095–9.
11. Galloway JB, Hyrich KL, Mercer LK et al. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70 (10): 1810–4.
12. Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol 2003; 17 (2): 201–8.
13. Cucurull E, Espinosa LR. Gonococcal arthritis. Rheum Dis Clin North America 1998; 24: 305–22.
14. Kaandorp CJ, van Schaardenburg D, Krijnen P et al. Risk factors for septic arthritis in patient with joint disease. A prospective study. Arthritis Rheum 1995; 38: 1819–25.
15. Rodríguez-Baño J, del Toro MD, Lupión C et al. Arthroplasty-related infection: incidence, risk factors, clinical features, and outcome. Enferm Infecc Microbiol Clin 2008; 26 (10): 614–20.
16. Müller M, Morawietz L, Hasart O et al. Diagnosis of periprosthetic infection following total hip arthroplasty – evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008; 3: 31.
17. Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA 2007; 297 (13): 1478–88.
18. Paosong S, Narongroeknawin P, Pakchotanon R et al. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Int J Rheum Dis 2015; 18 (3): 352–9.
19. Shaikh MM, Hermans LE, van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology 2015; 54 (2): 231–40.
20. Schäfer P, Fink B, Sandow D et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 2008; 47 (11): 1403–9.
21. Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357 (7): 654–63.
22. Workgroup Convened by the Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplasty 2011; 26 (8): 1136–8.
23. Osmon DR, Berbari EF, Berendt AR et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56 (1): e1–e25.
24. Rao N. Septic arthritis. Curr Treat Opt Infect Dis 2002; 4: 279–87.
25. Trampuz A, Steckelberg JM. Septic arthritis. Curr Treat Opt Infect Dis 2003; 5: 337–44.
26. Urologic surgery antimicrobial prophylaxis. Pocket Guide, May 15, 2013 version. URL: http://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis-PocketTable.p...
________________________________________________
2. Kennedy N, Chambers ST, Nolan I et al. Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population. J Rheumatol 2015; 42 (12): 2392–7.
3. Ohl CA, Forster D. Infectious arthritis of native joints. In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier-Saunders, 2015; p. 1302–17.
4. Khramov A.E., Makarov M.A., Bialik E.I. i dr. Problemy diagnostiki, profilaktiki i lecheniia periproteznoi infektsii u bol'nykh revmaticheskimi zabolevaniiami. Nauchno-prakticheskaia revmatologiia. 2015; 5: 558–63. [in Russian]
5. Pichkhadze I.M., Zhadin A.V., Kuz'menkov V.A. i dr. Lechenie bol'nykh s gnoino-vospalitel'nymi oslozhneniiami posle endoprotezirovaniia tazobedrennogo sustava. Vestn. travmatologii i ortopedii im. N.N.Priorova. 2009; 3: 45–50. [in Russian]
6. Colavite PM, Sartori A. Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis 2014; 20: 19.
7. Lahmann JD, Lahmann SJ. Etiology of septic arthritis in children: an update for the 1990s. Pediatr Emerg Care 1999; 15: 40–2.
8. Wang DA, Tambyah PA. Septic arthritis in immunocompetent and immunosuppressed hosts. Best Pract Res Clin Rheumatol 2015; 29 (2): 275–89.
9. Maki DG. Risk for septic arthritis was increased in adults with incident diagnosis of gout. Ann Intern Med 2015; 163 (12): JC12.
10. Lim SY, Lu N, Choi HK. Septic arthritis in gout patients: a population-based cohort study. Rheumatology (Oxford) 2015; 54 (11): 2095–9.
11. Galloway JB, Hyrich KL, Mercer LK et al. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70 (10): 1810–4.
12. Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol 2003; 17 (2): 201–8.
13. Cucurull E, Espinosa LR. Gonococcal arthritis. Rheum Dis Clin North America 1998; 24: 305–22.
14. Kaandorp CJ, van Schaardenburg D, Krijnen P et al. Risk factors for septic arthritis in patient with joint disease. A prospective study. Arthritis Rheum 1995; 38: 1819–25.
15. Rodríguez-Baño J, del Toro MD, Lupión C et al. Arthroplasty-related infection: incidence, risk factors, clinical features, and outcome. Enferm Infecc Microbiol Clin 2008; 26 (10): 614–20.
16. Müller M, Morawietz L, Hasart O et al. Diagnosis of periprosthetic infection following total hip arthroplasty – evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008; 3: 31.
17. Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA 2007; 297 (13): 1478–88.
18. Paosong S, Narongroeknawin P, Pakchotanon R et al. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Int J Rheum Dis 2015; 18 (3): 352–9.
19. Shaikh MM, Hermans LE, van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology 2015; 54 (2): 231–40.
20. Schäfer P, Fink B, Sandow D et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 2008; 47 (11): 1403–9.
21. Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357 (7): 654–63.
22. Workgroup Convened by the Musculoskeletal Infection Society. New definition for periprosthetic joint infection. J Arthroplasty 2011; 26 (8): 1136–8.
23. Osmon DR, Berbari EF, Berendt AR et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56 (1): e1–e25.
24. Rao N. Septic arthritis. Curr Treat Opt Infect Dis 2002; 4: 279–87.
25. Trampuz A, Steckelberg JM. Septic arthritis. Curr Treat Opt Infect Dis 2003; 5: 337–44.
26. Urologic surgery antimicrobial prophylaxis. Pocket Guide, May 15, 2013 version. URL: http://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis-PocketTable.p...
Авторы
Б.С.Белов*, С.А.Макаров, Е.И.Бялик
ФГБНУ Научно-исследовательский институт ревматологии им. В.А.Насоновой. 115522, Россия, Москва, Каширское ш., д. 34а
*belovbor@yandex.ru
ФГБНУ Научно-исследовательский институт ревматологии им. В.А.Насоновой. 115522, Россия, Москва, Каширское ш., д. 34а
*belovbor@yandex.ru
________________________________________________
B.S.Belov*, S.A.Makarov, E.I.Bialik
V.A.Nasonova Research Institute of Rheumatology. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34A
*belovbor@yandex.ru
V.A.Nasonova Research Institute of Rheumatology. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34A
*belovbor@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.